These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32578473)

  • 1. Improving Medication Adherence in an ACO Primary Care Office With a Pharmacist-Led Clinic: A Report From the ACORN SEED.
    Hale G; Moreau C; Joseph T; Phyu J; Merly N; Tadros N; Rodriguez MM
    J Pharm Pract; 2021 Dec; 34(6):888-893. PubMed ID: 32578473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pharmacist-Led, Patient-Centered Program Incorporating Motivational Interviewing for Behavior Change to Improve Adherence Rates and Star Ratings in a Medicare Plan.
    Spears J; Erkens J; Misquitta C; Cutler T; Stebbins M
    J Manag Care Spec Pharm; 2020 Jan; 26(1):35-41. PubMed ID: 31880222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating a Pharmacist-Led Intervention on Cardiovascular- and Diabetes-Related Quality Measures in a Primary Care-Based Accountable Care Organization.
    Joseph T; Hale G; Moreau C; Rosario ED; Logan N; Perez A
    J Pharm Pract; 2022 Jun; 35(3):363-368. PubMed ID: 33302778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a Clinical Pharmacist Medication Therapy Management Program in Discontinuation of Drugs to Avoid in the Elderly.
    Caffiero N; Delate T; Ehizuelen MD; Vogel K
    J Manag Care Spec Pharm; 2017 May; 23(5):525-531. PubMed ID: 28448783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an adherence intervention program on patient adherence and star ratings measures in a large community pharmacy chain.
    Johnson K; Kirby J; Kayse A; Brookhart A; Frede S; Hincapie A
    J Am Pharm Assoc (2003); 2020; 60(4):e70-e78. PubMed ID: 32229088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a pharmacist-driven medication adherence enhancement service.
    Rinehart SN; Collins C; Glover J; Rice WM
    J Manag Care Spec Pharm; 2021 Apr; 27(4):507-515. PubMed ID: 33769859
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
    Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
    J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Pharmacist-Driven Interventions in a Primary Care Setting to Improve Proportion of Days Covered and Medication Adherence.
    Davis DD; Hale G; Moreau C; Joseph T; Perez A; Rosario E
    J Pharm Pract; 2024 Feb; 37(1):27-34. PubMed ID: 35981874
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted Medications.
    Parekh N; Munshi KD; Hernandez I; Gellad WF; Henderson R; Shrank WH
    Value Health; 2019 Nov; 22(11):1266-1274. PubMed ID: 31708063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence.
    Daly CJ; Verrall K; Jacobs DM
    J Pharm Pract; 2021 Oct; 34(5):694-702. PubMed ID: 31884874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries.
    Moczygemba LR; Barner JC; Gabrillo ER; Godley PJ
    Am J Health Syst Pharm; 2008 Sep; 65(17):1655-60. PubMed ID: 18714113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration Strategies of Pharmacists in Primary Care-Based Accountable Care Organizations: A Report from the Accountable Care Organization Research Network, Services, and Education.
    Joseph T; Hale GM; Eltaki SM; Prados Y; Jones R; Seamon MJ; Moreau C; Gernant SA
    J Manag Care Spec Pharm; 2017 May; 23(5):541-548. PubMed ID: 28448780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients.
    Zillich AJ; Snyder ME; Frail CK; Lewis JL; Deshotels D; Dunham P; Jaynes HA; Sutherland JM
    Health Serv Res; 2014 Oct; 49(5):1537-54. PubMed ID: 24712335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tennessee medication therapy management program: A hybrid type 2 effectiveness-implementation trial study protocol.
    Woeppel J; Clark R; Underwood L; Gatwood J; Turner K; Renfro C; Hohmeier KC
    Res Social Adm Pharm; 2020 Mar; 16(3):315-320. PubMed ID: 31151919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.